组织蛋白酶S的研究进展

被引:10
作者
王林燕
王博
戴灵豪
杜仲燕
关旸
丁美红
机构
[1] 浙江中医药大学药学科研中心公共平台
基金
浙江省自然科学基金;
关键词
组织蛋白酶S; 上下游通路; 活性检测; 抑制剂;
D O I
暂无
中图分类号
R3411 [];
学科分类号
摘要
组织蛋白酶S(Cat S)是半胱氨酸蛋白酶的重要一员,主要分布在淋巴结、脾脏、肺等器官,多在表达主要组织相容性复合物Ⅱ的细胞中表达,在抗原递呈中发挥重要作用,参与疾病的发生、发展过程。Cat S还与炎症因子相互作用,参与体内免疫及炎症反应,在心血管、免疫系统和肿瘤等疾病的发生、发展过程中发挥重要作用。本文通过概述Cat S的结构、与疾病的关系、上下游通路、活性检测方法及抑制剂等方面内容,为今后开展Cat S的研究提供部分参考。
引用
收藏
页码:488 / 492
页数:5
相关论文
共 15 条
[1]
组织蛋白酶S在类风湿关节炎中的作用 [D]. 
赵进军 .
南方医科大学,
2014
[2]
A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.[J].Alex Steimle;Hubert Kalbacher;Andreas Maurer;Brigitte Beifuss;Annika Bender;Andrea Schäfer;Ricarda Müller;Ingo B. Autenrieth;Julia-Stefanie Frick.Journal of Immunological Methods.2016,
[3]
The Application of a Novel; Cell Permeable Activity-Based Probe for the Detection of Cysteine Cathepsins.[J].Caroline S. Hughes;George Shaw;Roberta E. Burden;Christopher J. Scott;Brendan F. Gilmore.Biochemical and Biophysical Research Communicatio.2016,
[4]
Active site labeling of cysteine cathepsins by a straightforward diazomethylketone probe derived from the N-terminus of human cystatin C [J].
Garenne, Thibaut ;
Saidi, Ahlame ;
Gilmore, Brendan F. ;
Niemiec, Elzbieta ;
Roy, Vincent ;
Agrofoglio, Luigi A. ;
Kasabova, Mariana ;
Lecaille, Fabien ;
Lalmanach, Gilles .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (02) :250-254
[5]
Selective Cathepsin S Inhibition Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice with Chronic Renal Disease.[J].Jose-Luiz Figueiredo;Masanori Aikawa;Chunyu Zheng;Jacob Aaron;Lilian Lax;Peter Libby;Jose Luiz de Lima Filho;Sabine Gruener;Jürgen Fingerle;Wolfgang Haap;Guido Hartmann;Elena Aikawa.The American Journal of Pathology.2015, 4
[6]
In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin S Substrate<link href="#nss"/>.[J].Hai‐Yu Hu;Divya Vats;Matej Vizovisek;Lovro Kramer;Catherine Germanier;K. Ulrich Wendt;Markus Rudin;Boris Turk;Oliver Plettenburg;Carsten Schultz.Angew. Chem. Int. Ed..2014, 29
[7]
Pharmacophore-Based 3DQSAR and Molecular Docking Studies to Identify New Non-Peptidic Inhibitors of Cathepsin S [J].
Battu, M. B. ;
Chandra, A. M. ;
Sriram, D. ;
Yogeeswari, P. .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (16) :1910-1921
[8]
Spinal cathepsin S and fractalkine contribute to chronic pain in the collagen-induced arthritis model [J].
Clark, Anna K. ;
Grist, John ;
Al-Kashi, Adam ;
Perretti, Mauro ;
Malcangio, Marzia .
ARTHRITIS AND RHEUMATISM, 2012, 64 (06) :2038-2047
[9]
Genetic and Pharmacological Evaluation of Cathepsin S in a Mouse Model of Asthma [J].
Deschamps, Kathleen ;
Cromlish, Wanda ;
Weicker, Sean ;
Lamontagne, Sonia ;
Huszar, Sarah L. ;
Gauthier, Jacques Yves ;
Mudgett, John S. ;
Guimond, Alain ;
Romand, Raymond ;
Frossard, Nelly ;
Percival, M. David ;
Slipetz, Deborah ;
Tan, Christopher M. .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 45 (01) :81-87
[10]
Cathepsin S inhibitors: 2004 – 2010.[J].Alice Lee-Dutra;Danielle K Wiener;Siquan Sun.Expert Opinion on Therapeutic Patents.2011, 3